Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: SNTX
N-terminal Telopeptide (NTx), Serum
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Monitoring effectiveness of antiresorptive therapy in patients treated for osteoporosis or other metabolic bone disorders
As an adjunct in the diagnosis of medical conditions associated with increased bone turnover
Highlights
Elevated levels of N-terminal telopeptide (NTx) indicate increased bone resorption.
Measurement of serum NTx is helpful for monitoring effectiveness of antiresorptive therapies in patients treated for osteoporosis or other metabolic bone disorders.
A 30% or greater reduction in NTx serum concentrations 3 to 6 months after initiation of therapy indicates a probably adequate therapeutic response.
Method Name A short description of the method used to perform the test
Enzyme-Linked Immunosorbent Assay (ELISA)
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
NTX-Telopeptide, S
Aliases Lists additional common names for a test, as an aid in searching
Collagen Crosslinks
Crosslinked N-telopeptide of Type I Collagen (NTX), Serum
N-Telopeptide, Serum
NTX
Osteomark
Osteoporosis
Crosslinked N-telopeptide of Type I Collagen (NTX), Serum
N-Telopeptide, Serum
NTX
Osteomark
Osteoporosis